Apeximmune Therapeutics
Burlingame
About Apeximmune Therapeutics
Apeximmune Therapeutics is pioneering a new generation of therapeutic antibodies and biologics that harness the power of the immune system to deliver curative treatments for cancer and autoimmune disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $21.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2025)
- Website: apeximmune.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Diagnostics, Life Science
Social Profiles
Canonical: https://fsome.com/organization/apeximmune-therapeutics-52568 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.